TSS
EDSA icon

Two Sigma Securities’s Edesa Biotech EDSA Stock Holding History

Two Sigma Securities’s Portfolio EDSA Stock Details EDSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,313
Closed -$25.7K – 1638
2024
Q4 		$25.7K Buy
+15,313
New +$42.6K ﹤0.01% 1271
2019
Q2 		– Sell
-265
Closed -$12K – 2146
2019
Q1 		$12K Buy
+265
New +$13.1K ﹤0.01% 1716
2018
Q4 		– Sell
-482
Closed -$28K – 2306
2018
Q3 		$28K Buy
482
+136
+39% +$8.66K ﹤0.01% 2403
2018
Q2 		$26K Buy
+346
New +$49.5K ﹤0.01% 2548

Other funds holding EDSA

RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Two Sigma Securities's EDSA Position: Q1 2025 in Review

Two Sigma Securities sold out of Edesa Biotech (EDSA) in Q1 2025, closing a stake of 15,313 shares — an estimated $25.7K sold.

Two Sigma Securities first reported a position in EDSA in Q2 2018 and held it in 4 quarters. The position peaked at $28K in Q3 2018. 20 funds tracked by Wall St. Rank hold EDSA as of Q1 2025.

  • Two Sigma Securities reported no remaining Edesa Biotech position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 15,313 Edesa Biotech shares in Q1 2025, an estimated $25.7K.
  • Two Sigma Securities first reported a position in Edesa Biotech in Q2 2018 and held it in 4 quarters.
  • Two Sigma Securities's Edesa Biotech position peaked at $28K in Q3 2018.
  • 20 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.